{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20240806",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "79334",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/212904Orig1s002ltr.pdf",
              "date": "20240808",
              "type": "Letter"
            },
            {
              "id": "79336",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212904s002lbl.pdf",
              "date": "20240808",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210310",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "66745",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/212904Orig1s000ltr.pdf",
              "date": "20210311",
              "type": "Letter"
            },
            {
              "id": "66912",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212904s000lbl.pdf",
              "date": "20210329",
              "type": "Label"
            },
            {
              "id": "66993",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/212904Orig1s000TOC.html",
              "date": "20210427",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20250130",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "80969",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212904s003lbl.pdf",
              "date": "20250205",
              "type": "Label"
            },
            {
              "id": "81096",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/212904Orig1s003ltr.pdf",
              "date": "20250206",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA212904",
      "sponsor_name": "AVEO PHARMS",
      "openfda": {
        "application_number": [
          "NDA212904"
        ],
        "brand_name": [
          "FOTIVDA"
        ],
        "generic_name": [
          "TIVOZANIB"
        ],
        "manufacturer_name": [
          "AVEO Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "45629-089",
          "45629-134"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "TIVOZANIB HYDROCHLORIDE"
        ],
        "rxcui": [
          "2534238",
          "2534244",
          "2534247",
          "2534249"
        ],
        "spl_id": [
          "40222ff4-0ffc-318f-e063-6294a90aadc2"
        ],
        "spl_set_id": [
          "de77155c-ecf2-4f15-9758-21d271449d83"
        ],
        "package_ndc": [
          "45629-089-01",
          "45629-089-02",
          "45629-134-01",
          "45629-134-02"
        ],
        "unii": [
          "8A9H4VK35Z"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "FOTIVDA",
          "active_ingredients": [
            {
              "name": "TIVOZANIB HYDROCHLORIDE",
              "strength": "EQ 1.34MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "CAPSULE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "FOTIVDA",
          "active_ingredients": [
            {
              "name": "TIVOZANIB HYDROCHLORIDE",
              "strength": "EQ 0.89MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "CAPSULE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}